[go: up one dir, main page]

GT200600119A - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
GT200600119A
GT200600119A GT200600119A GT200600119A GT200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A GT 200600119 A GT200600119 A GT 200600119A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical compositions
humid
preparation
granulation process
therapeutic substance
Prior art date
Application number
GT200600119A
Other languages
English (en)
Inventor
Katja Jores
Andreas Meyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600119A publication Critical patent/GT200600119A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA A COMPOSICIONES FARMACÉUTICAS ESPECÍFICAMENTE A PROCESO DE GRANULACIÓN VIA HÚMEDA PARA LA PREPARACIÓN DE GRÁNULOS QUE CONTIENE UNA SUSTANCIA TERAPÉUTICA QUE PUEDEN SER UTILIZADOS PARA PREPARAR COMPOSICIONES FARMACÉUTICAS.
GT200600119A 2005-03-24 2006-03-17 Composiciones farmaceuticas GT200600119A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66473305P 2005-03-24 2005-03-24

Publications (1)

Publication Number Publication Date
GT200600119A true GT200600119A (es) 2006-10-25

Family

ID=37024189

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600119A GT200600119A (es) 2005-03-24 2006-03-17 Composiciones farmaceuticas

Country Status (15)

Country Link
US (1) US20080207533A1 (es)
EP (1) EP1865926A2 (es)
JP (1) JP2008546635A (es)
KR (1) KR20080011278A (es)
CN (1) CN101146519A (es)
AR (1) AR052952A1 (es)
AU (1) AU2006226521A1 (es)
BR (1) BRPI0609442A2 (es)
CA (1) CA2602000A1 (es)
GT (1) GT200600119A (es)
MX (1) MX2007011704A (es)
PE (1) PE20061352A1 (es)
RU (1) RU2007139105A (es)
TW (1) TW200724168A (es)
WO (1) WO2006100087A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
MXPA02011691A (es) 2000-05-26 2004-05-17 Idenix Cayman Ltd Metodos y composiciones para el tratamiento de flavivirus y pestivirus.
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
JP2005533824A (ja) 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウイルス科感染の治療のための２’−ｃ−メチル−３’−ｏ−ｌ−バリンエステルリボフラノシルシチジン
PL377342A1 (pl) 2002-11-15 2006-01-23 Idenix (Cayman) Limited Nukleozydy rozgałęzione w pozycji 2' oraz mutacja Flaviviridae
AU2003300901A1 (en) 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
US9814776B2 (en) * 2013-07-31 2017-11-14 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparation comprising aminopyrazole derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533824A (ja) * 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウイルス科感染の治療のための２’−ｃ−メチル−３’−ｏ−ｌ−バリンエステルリボフラノシルシチジン

Also Published As

Publication number Publication date
JP2008546635A (ja) 2008-12-25
US20080207533A1 (en) 2008-08-28
PE20061352A1 (es) 2007-01-11
WO2006100087A2 (en) 2006-09-28
BRPI0609442A2 (pt) 2010-04-06
WO2006100087A3 (en) 2007-02-15
RU2007139105A (ru) 2009-04-27
CN101146519A (zh) 2008-03-19
AU2006226521A1 (en) 2006-09-28
MX2007011704A (es) 2007-11-15
TW200724168A (en) 2007-07-01
KR20080011278A (ko) 2008-02-01
EP1865926A2 (en) 2007-12-19
CA2602000A1 (en) 2006-09-28
AR052952A1 (es) 2007-04-11

Similar Documents

Publication Publication Date Title
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
CR10479A (es) Modulares bencimidazolicos de vr1
ECSP11010834A (es) Formulaciones farmacéuticas que contienen ligandos de receptores de dopamina
NO20090554L (no) Farmasoytiske preparater av memantin
BRPI0915084B8 (pt) composto, e, composição farmacêutica
NO20073722L (no) Farmasoystiske sammensetniger omfattende bendamustin
SV2011003786A (es) Compuestos quimicos 251
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA201101341A1 (ru) Соединения, ингибирующие киназы, и фармацевтическая композиция на их основе
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
CR11285A (es) Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma
BR122017015098B8 (pt) formulações farmacêuticas de liberação imediata que contêm hidrato de propileno glicol de dapagliflozina
SV2011003855A (es) Heteroarilos sustituidos
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
BRPI0706992C8 (pt) composto de fórmula (i) e formulação farmacêutica
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BRPI0916622A2 (pt) derivados de piperazina usados como moduladores de canal de cálcio cav2,2
GT200600119A (es) Composiciones farmaceuticas
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
AR070392A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion
EA200900254A1 (ru) Производные 1h-индол-2-карбоновой кислоты, полезные в качестве модуляторов ppar
CL2008001325A1 (es) Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades.